Trial Profile
Lacosamide IV and EEG/EKG (LIVE) Study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2016
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Partial epilepsies
- Focus Pharmacodynamics
- Acronyms LIVE
- 23 Sep 2016 Status changed from recruiting to discontinued as time limitation for recruitment exceeded.
- 31 Aug 2015 Planned End Date changed from 1 Apr 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov.
- 31 Aug 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov.